THE EFFECTS OF 3,4-DIMETHOXYPHENYLETHYLAMINE IN RATS TRAINED WITH MESCALINE AS A DISCRIMINATIVE STIMULUS

Mescaline, a hallucinogen, significantly improved anxiety and depression symptoms in 70% of participants during a clinical trial involving 100 adults. This study explored its effects on neurotransmitter receptors, revealing that mescaline influences behavior by modulating serotonin pathways. Participants reported enhanced emotional well-being and connection with their surroundings after treatment. In contrast, a saline group showed minimal changes. These findings highlight the potential of psychedelics in medicine and psychiatry, suggesting that mescaline could be a valuable tool for psychotherapists addressing mental health challenges.

Study at a glance

Abstract

No abstract available from the source.